Though we did not have concurrent data to assess the relationship between CD4 count and nasopharyngeal microbiome composition, our data suggest ART-treated HIV infection does not substantially impact the nasopharyngeal microbiome in the presence or absence of SARS-CoV-2 infection. The gene discussed is CD4; the disease is HIV infectious disease.